The pediatric heart network: meeting the challenges to multicenter studies in pediatric heart disease
- PMID: 26196261
- PMCID: PMC5382713
- DOI: 10.1097/MOP.0000000000000260
The pediatric heart network: meeting the challenges to multicenter studies in pediatric heart disease
Abstract
Purpose of review: Because of the relatively small numbers of pediatric patients with congenital heart disease cared for in any individual center, there is a significant need for multicenter clinical studies to validate new medical or surgical therapies. The Pediatric Heart Network (PHN), with 15 years of experience in multicenter clinical research, has tackled numerous challenges when conducting multicenter studies.
Recent findings: This review describes the challenges encountered and the strategies employed to conduct high-quality, collaborative research in pediatric cardiovascular disease.
Summary: Sharing lessons learned from the PHN can provide guidance to investigators interested in conducting pediatric multicenter studies.
Conflict of interest statement
Disclosures: no disclosures or conflicts of interest. This article has not been published in its current form or similar form, has not been accepted for publication elsewhere, and is not under consideration by another publication.
No disclosures or conflicts of interest. The comments expressed here are those of the authors, and do not reflect official positions of the National Heart, Lung, and Blood Institute or NIH.
Figures
References
-
- Hill KD, Chiswell K, Califf RM, et al. Characteristics of pediatric cardiovascular clinical trials registered on clinicaltrials. Gov Am Heart J. 2014;167:921–929 e922. This study examines the portfolio of clinical trials registered in clinicaltrials.gov. Of the 68,000 trials, only 5000 are pediatric trials, and only 284 were focused on pediatric cardiovascular interventions. - PMC - PubMed
-
- Mahony L, Sleeper LA, Anderson PA, et al. The pediatric heart network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol. 2006;27:191–198. - PubMed
-
- Lacro RV, Dietz HC, Sleeper LA, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med. 2014;371:2061–2071. This randomized clinical trial of 608 individuals 6 months–25 years of age with Marfan syndrome and aortic root dilation compared atenolol with losartan. After 3 years of treatment, there was no difference in the rate aortic root dilation between the groups. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials